ABNORMAL levels of pulmonary eicosanoids have been reported in infants with persistent pulmonary hypertension (PPH) and congenital diaphragmatic hernia (CDH). We hypothesized that a dysbalance of vasoconstrictive and vasodilatory eicosanoids is involved in PPH in CDH patients. The levels of several eicosanoids in lung homogenates and in bronchoalveolar lavage uid of controls and rats with CDH were measured after caesarean section or spontaneous birth. In controls the concentration of the stable metabolite of prostacyclin (6-keto-PGF 1a), thrombox ane A2 (Tx B 2 ), prostaglandin E 2 (PGE 2 ), and leukotriene B 4 (LTB 4 ) decreased after spontaneous birth. CDH pups showed respiratory insuf ciency directly after birth. Their lungs had higher levels of 6-keto-PGF 1a , re ecting the pulmonary vasodilator prostacyclin (PGI 2 ), than those of controls. We conclude that in CDH abnormal lung eicosanoid levels are present perinatally. The elevated levels of 6-keto-PGF 1a in CDH may re ect a compensation mechanism for increased vascular resistance.
Introduction
Eicosanoids are arachidonic acid metabolites which are produced in different tissues in human and animal species. 1 They have been studied extensively in relation to the perinatal pulmonary circulation, and have been implicated in several physiologic and pathologic conditions such as persistent pulmonary hypertension (PPH). 2 7 Prostacyclin (PGI 2 ), prostaglandin E 2 (PGE 2 ), and thromboxane A 2 (TxA 2 ) are all generated via the cyclooxygenase pathway; the latter has a pulmonary vasoconstricting activity, whereas the other two are pulmonary vasodilators. 6 Increased circulating levels of PGE 2 may contribute to the pathogenesis of patent ductus arteriosus. 8 Leukotrienes, which are formed by the 5-lipoxygenase pathway, may have a key function in maintaining the elevated pulmonary vascular resistance in the fetus, 6 ,9 although this could not be con rmed in other studies. 7, 10 Children with congenital diaphragmatic hernia (CDH) have abnormal morphological development of lungs and intrapulmonary blood vessels. 11, 12 The high neonatal mortality and morbidity is ascribed to the extent of lung hypoplasia and PPH. 13 Increased levels of leukotrienes, and of metabolites of PGI 2 and TxA 2 have been reported in plasma and in bronchoalveolar lavage (BAL) uid of both PPH patients without CDHand children with CDH. 14 21 We hypothesized that the pulmonary vascular abnormalities in CDH cause abnormal transition of the pulmonary circulation at birth, associated with a dysbalance of vasoconstrictive and vasodilatory eicosanoids. Therefore, we studied the content of different eicosanoids-metabolites from the cyclooxygenase and one from the lipoxygenase pathway-in lung homogenates and in BAL uid of perinatal rats with CDH. 22 The pulmonary vascular abnormalities in these rat pups strongly resemble those of children with CDH.
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Materials and Methods
Animal model
Female Sprague-Dawley rats (Harlan Olac, UK) were mated during 1 h (day 0 of gestation). Nine of 18 pregnant rats received 100 mg of 2,4-dichloro-phenyl-p-nitrophenylether (Nitrofen: Rohm Haas Company, Philadelphia, PA) in 1 ml of olive oil orogastrically under light ether anaesthesia on day 10 of gestation;
22 the remaining nine rats provided control pups. Nitrofen induces a large left-sided diaphragmatic defect with severe lung hypoplasia in up to 80%of the offspring using this regimen. 22 Food and water were supplied ad libitum during the whole period of pregnancy. Nine pregnant dams were anaesthetized by inhalation of diethylether and a caesarean section was performed on day 22 (nitrofen-exposed litters n 5; control litters n 4). While they were kept in the membranes to prevent any breathing, the fetuses died after cervical intersection with a needle, and were weighed. Only rat pups that could be processed within the rst 30 min of anaesthesia were included. In the remaining litters (nitrofenexposed n 4, and controls n 5) spontaneous birth on day 22± 23 was awaited; within 5± 10 min after birth they were killed as described above, and weighed. The presence of a diaphragmatic defect in all nitrofen-exposed rat pups was revealed by autopsy. To obtain a homogeneous group only nitrofen-exposed rat pups with left-sided or bilateral diaphragmatic defects with concomitant severe lung hypoplasia were included, and nitrofen-exposed pups with small right-sided defects or without CDH were excluded. Thus four different groups were studied: CDH rat pups after caesarean section or born spontaneously, and control pups after caesarean section or born spontaneously. Either BAL procedure or dissection of the lungs for preparation of homogenates was then performed.
Lung homogenates
The lungs were removed, stripped of nonpulmonary tissue, separated, weighed, frozen in liquid N 2 , and stored at 708 C until further processed. They they were homogenized in 1 ml in Krebs-solution, and centrifuged at 2500 g. The content of eicosanoids and protein was measured in the supernatant. Ten samples were obtained in CDH pups after caesarean section and four in spontaneously born pups. In controls the numbers were n 11 and n 23, respectively.
BAL procedure
After opening of the abdominal cavity and assessment of the diaphragmatic defect in the nitrofen-exposed pups, the thorax was opened, and a tracheotomy was performed. A polyethylene catheter (Portex, UK; outer diameter 0.61 mm or 1.0 mm, inner diameter 0.28 or 0.5 mm, for CDH pups and controls respectively) was inserted into the trachea and ligated. A 1 ml-syringe with NaCl 0.9%, heated to 378 C, was connected to the catheter, and the lungs were washed as previously described. 24 In CDH pups the lungs were washed with seven to 10 times 0.05 to 0.1 ml. Lungs from control pups were washed four times with 0.25 to 0.45 ml, until 1 ml of uid had been recovered. Samples that were visibly contaminated with blood were excluded. Ten samples were obtained in each CDH group, and 13 samples in each control group. The BAL uid was directly frozen in liquid N 2 and stored at 708 C until assay.
Measurement of eicosanoids and total protein
The following eicosanoids were measured by radioimmunoassay: 6-keto-PGF 1a (the stable metabolite of prostacyclin), PGE 2 , TxB 2 (the stable metabolite of TxA 2 ), all three generated by the cyclooxygenase pathway, and leukotriene B 4 (LTB 4 ), a lipoxygenase-derived metabolite of arachidonic acid. All assays were performed as described in detail previously. 25 Total protein was measured by ELISA at 595 nm using a commercially available protein reagent and protein standard (Instruchemie B.V., Hilversum, the Netherlands).
Data analysis
All eicosanoid levels are expressed as pg/mg protein (mean SEM), unless stated otherwise. Differences between groups were tested by Student's t-test or by the non-parametric Mann± Whitney test if appropriate. Statistical signicance was assumed at 5%level.
Results
All spontaneously born control pups had a regular respiration rate and were pink within minutes after birth. Respiratory insuf ciency with gasping and cyanosis was observed in rat pups with CDH, but not in controls, directly after birth.
The lung weights in spontaneously born control pups were signi cantly lower than those in controls delivered by caesarean section (Table 1 ; P , 0.001). This was not the case in the CDH pups: the lung weights were similar in both groups (Table 1) . Control lungs were signi cantly heavier than lungs in CDH (P , 0.001).
Results in lung homogenates
First, data from the left and the right lungs in all groups were analysed separately to determine whether there were consistent differences in eicosanoid levels between the ipsilateral and contralateral lungs in CDH (data not shown). This was not the case, however, and data from both lungs were therefore pooled.
In CDH pups protein per mg wet lung weight was higher than in controls: 28.8 0.8 mg and 27.5 1.1 mg after caesarean section and spontaneous delivery in CDH, respectively, and 13.5 0.1 mg and 18.5 0.6 mg in controls, respectively (P , 0.001). In controls the protein content per mg lung weight was signi cantly lower in pups who were delivered by caesarean section than in spontaneously born pups (P , 0.001), but this was not true for the total protein content in both lungs (2020 9 mg after caesarean section and 2060 24 mg after spontaneous birth). In all control pups the total amount of protein was higher than in CDH pups, whose lungs contained 1760 12 mg and 1710 8 mg protein in the respective groups (P , 0.001).
The eicosanoid concentrations per mg protein measured in the lung homogenates are shown in Fig. 1 . In controls the concentrations of all eicosanoids per mg protein (Fig. 1A± D) and the total amount of eicosanoids (Table 1) were signi cantly lower in spontaneously born pups, compared with those in the caesarean section group. In CDH pups the eicosanoid levels were not affected by the delivery mode; this was also the case for the eicosanoid content per mg lung weight (data not shown).
The levels of 6-keto-PGF 1a per mg protein ( Fig. 1A ; P , 0.001) and the total amount of 6-keto-PGF 1a (Table 1 ; P , 0.001) were signicantly higher in CDH than in controls. In addition, the ratio of 6-keto-PGF 1a to TxB 2 was calculated for each group; in the caesarean section group it was 0.38 0.03 and 0.16 0.01 for CDH and controls, respectively (P , 0.001), and for spontaneously born rat pups 0.39 0.02 and 0.16 0.01, respectively (P , 0.001).
Controls born by caesarean section had higher total TxB 2 than CDH pups (Table 1 ; P 0.006) and a tendency towards higher TxB 2 per mg protein ( Fig. 1B; P 0.08) . No such differences for TxB 2 were observed in the spontaneously born rat pups. PGE 2 per mg protein was signi cantly higher in control pups delivered by caesarean section than in CDH pups ( Fig. 1C ; P 0.003). The total amounts of PGE 2 were higher in controls than in CDH pups, irrespective of the delivery mode ( Table 1 ). The concentration of LTB 4 per mg protein (Fig. 1D ) and the total amount of LTB 4 (Table 1) were signi cantly higher in controls than in CDH pups after caesarean section (P , 0.001), whereas both groups showed similar LTB 4 levels after spontaneous delivery.
Eicosanoids in BAL¯uid
In BAL uid a wide range of eicosanoid concentrations was observed. In controls the concentrations per ml BAL uid of 6-keto-PGF 1a , TxB 2 , and LTB 4 were higher after spontaneous birth than after caesarean section (Table 2 ; P 0.01, 0.06, and , 0.001, respectively). However, after correction for dilution, with total protein as marker, only LTB 4 was signi cantly higher after spontaneous birth (Table 2 ; P 0.02). CDH pups showed higher uncorrected concentration levels of TxB 2 and LTB 4 in spontaneously born rats compared with pups delivered by caesarean section (Table 2 ; P 0.04 and 0.05, respectively). The same volumes in CDH pups were so small that the protein concentration could only be measured in eight samples (n 4 per group). All data are expressed as mean SEM. The numbers per group are: n 11 and n 23 for the controls delivered by caesarean section and by spontaneous birth, respectively; n 10 and n 4 for the respective CDH groups. a Signi® cantly different from control, same delivery mode; P , 0.05. b Signi® cantly different from caesarean section, same group; P , 0.05.
The ratio of 6-keto-PGF 1a and TxB 2 in BAL uid was signi cantly higher in CDH pups than in controls who were delivered by caesarean section (7.93 2.95 and 2.22 0.5, respectively; P 0.02). A similar tendency was observed for the spontaneously born rat pups (3.63 1.13 for CDH, and 1.48 0.32 for controls; P 0.06). 
Discussion
In the present study higher levels of 6-keto-PGF 1a , the stable metabolite of the pulmonary vasodilator PGI 2 , were found in the lungs of CDH pups than in those of controls, irrespective of the mode of delivery. Lungs of CDH pups had similar or lower levels of TxB 2 , PGE 2 , and LTB 4 than control pups. All eicosanoids studied were higher in the lungs of control pups delivered by caesarean section than in those born spontaneously; this was not the case in CDH pups. The lower lung weights in spontaneously born controls compared with those delivered by caesarean section probably indicate that lung uid was absorbed to a large extent during the rst adequate breaths. The gasping, irregular breathing movement in the spontaneously born CDH pups have been insuf cient to overcome the pressure that is needed to initiate lung expansion and to provide adequate lung aeration and absorption of lung uid, 26, 27 thus explaining the similar lung weights in both CDH groups.
We studied the eicosanoid concentration both in lung homogenates and in BAL uid to determine whether the concentration in BAL uid adequately re ects the situation in the lung tissue. We found widely varying eicosanoid concentrations in BAL uid of the neonatal rat pups. After correction for protein, only the concentration of 6-keto-PGF 1a in control pups showed comparable results between BAL uid and lung homogenates. The concentration of TxB 2 was generally 10 times higher in lung homogenates than in BAL uid, which suggests that thromboxane is mainly present in the pulmonary vasculature and not into the airspaces. The same may be true for the concentration of LTB 4 during intrauterine life. Our data support earlier observations that the eicosanoid content in the pulmonary vasculature is more adequately re ected in tissue homogenates than in BAL uid. 7 However, the ratio of 6-keto-PGF 1a and TxB 2 was signi cantly higher in lung homogenates and in BAL uid of CDH pups than in that of controls, suggesting that this parameter in BAL uid re ects the values in lung tissue. A high ratio of 6-keto-PGF 1a and TxB 2 was also found in BAL uid of two CDH patients with evidence of PPH (unpublished data).
During normal transition from intrauterine to extrauterine life, the pulmonary vascular resistance rapidly declines within the rst 30 s, and declines more slowly over the next 10± 20 min. 2 The rst phase occurs irrespective of prostaglandin synthase blockade by indomethacin, 2 but several studies in lambs and goats indicate that a transient prostacyclin production in the lungs, which is stimulated by tissue stress during establishment of gaseous ventilation and rhythmic ventilation, 4 is important to sustain further pulmonary vasodilatation within the rst hours after birth. 2 4,7 The lower levels of all eicosanoids in lung tissue of normal controls compared with CDH pups following spontaneous birth in this study seem to contradict the earlier ndings in newborn lambs and goats. 2 4,7 Perhaps the described loss of prostacyclin from the lungs shortly before birth 3 continued immediately after birth, and the rat pups died before the prostacyclin concentration began to increase. However, the CDH pups could not survive much longer without arti cial ventilation and supplemental oxygen.
Persistent pulmonary hypertension is a serious problem in neonatology which largely contributes to the neonatal mortality and morbidity in isolated cases of PPH, 28 and in children with CDH. 13 Improvement of oxygenation parameters in some children with PPH has been reported after intravenous or inhaled administration of prostacyclin, 29, 30 although other patients seem irresponsive to vasodilator therapy like prostacyclin 29 or inhaled nitric oxide. 28 Increased levels of 6-keto-PGF 1a , TxB 2 , PGE 2 , and leukotrienes have been reported in plasma and in bronchoalveolar lavage uid of PPH patients 14, 17, 19, 21 and in plasma of CDH patients with PPH. 15, 16, 21 A decrease in all eicosanoid levels was observed during clinical improvement, especially in patients who were being treated with extracorporeal membrane oxygenation. 16, 21 It has been suggested that LTC 4 , LTD 4 and TxB 2 have a pulmonary vasoconstricting activity, whereas 6-keto-PGF 1a opposes the hypoxic vasoconstriction. 31 In a fetal lamb model of chronic intrauterine pulmonary hypertension 32 increased pulmonary levels of 6-keto-PGF 1a and TxB 2 were detected shortly before, and 2 h after birth. 7 Our study did not reveal signi cant differences in eicosanoid content in the lungs of the CDH rats during transition from intrauterine to extrauterine life; this may be due to the short period of survival after birth and the lack of adequate respiratory movements.
We found increased levels of 6-keto-PGF 1a per mg protein, and decreased levels of PGE 2 and LTB 4 in lung tissue of CDH pups in the caesarean section group. Surprisingly, the concentration of TxB 2 per mg protein was similar in CDH pups and in controls. We assumed that a certain total amount of eicosanoids is important to exert a local effect, and we therefore determined the total eicosanoid content in both lungs of CDH and control pups. The results were similar to the data that were corrected for protein. The increased ratio of 6-keto-PGF 1a and TxB 2 in CDH pups compared with control pups con rms the presence of a dysbalance in vasoactive mediators, which is in favour of the pulmonary vasodilator. It has been suggested that prostaglandin generation in the pulmonary vasculature may reduce the pulmonary vascular pressure response to hypoxia. 31 Cott and coworkers 33 showed in adult rats that alveolar type II cells are capable of producing high levels of 6-keto-PGF 1a and PGE 2 in vitro, whereas TxB 2 and LTB 4 are mainly produced by alveolar macrophages. Brandsma and coworkers 34 reported more type II cells that showed retarded differentiation in CDH lungs. The relatively higher number of type II cells may be responsible for the increased 6-keto-PGF 1a content in the CDH lungs.
In conclusion, the present study shows different eicosanoid pro les in lungs of perinatal rats with and without CDH. The most striking ndings are the elevated concentration of 6-keto-PGF 1a , and the increased ratio of 6-keto-PGF 1a and TxB 2 in CDH lungs. This is the rst study of lung eicosanoids in perinatal animals with abnormal lung development. From the present data it is not clear whether the balance which is in favour of 6-keto-PGF 1a , the stable metabolite of the pulmonary vasodilator PGI 2 , compensates for an increased pulmonary vascular tone or that it re ects delayed cell differentiation in CDH. Our ndings give reason to assume that lungs of CDH patients with PPH already contain increased levels of prostacyclin at birth and that the administration of exogenous vasodilators will not be helpful to decrease the pulmonary vascular resistance in those patients.
